Suneela Mehta - Epidemiology

Author Information

Suneela Mehta is an esteemed researcher affiliated with the Section of Epidemiology and Biostatistics at The University of Auckland, Auckland, New Zealand. With a focus on cardiovascular disease and preventive medicine, Suneela Mehta has made significant contributions to the field of Epidemiology through extensive research and numerous publications.

Research Contributions

Suneela Mehta's research primarily revolves around cardiovascular disease prevention, risk prediction models, and the impact of socioeconomic factors on health outcomes. Notable works include studies on cardiovascular disease preventive medication dispensing, cardiovascular risk prediction in type 2 diabetes, and the analysis of dietary intakes in patients with Acute Coronary Syndrome. Mehta's work also explores the suitability of competing-risk models over standard Cox models for predicting cardiovascular risk in older adults and studies risk stratification by ethnicity and socioeconomic deprivation. These contributions have provided valuable insights into the prevention and management of cardiovascular diseases, particularly within the New Zealand population.

Aliases

Suneela Mehta is also known by the aliases "S Mehta" and "S. Mehta."

Publication and Citation Metrics

Metric	Value
Citation Count	576
h-index	14
Paper Count	40

Publications:

Cardiovascular disease preventive medication dispensing for almost every New Zealander 65 years and over: a preventive treatment paradox?

DOI: 10.1093/ageing/afab265

Year: 2022

Are competing-risk models superior to standard Cox models for predicting cardiovascular risk in older adults? Analysis of a whole-of-country primary prevention cohort aged ≥65 years.

DOI: 10.1093/ije/dyab116

Year: 2021

Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study

DOI: 10.1016/S0140-6736(21)00572-9

Year: 2021

267Cardiovascular preventive pharmacotherapy stratified by cardiovascular risk in a complete New Zealand primary prevention population

DOI: 10.1093/ije/dyab168.427

Year: 2021

960Dietary intakes of patients with first Acute Coronary Syndrome: the MENZACS study

DOI: 10.1093/ije/dyab168.094

Year: 2021

Cardiovascular preventive pharmacotherapy stratified by predicted cardiovascular risk: a national data linkage study.

DOI: 10.1093/eurjpc/zwaa168

Year: 2021

Risk of Major Bleeding by Ethnicity and Socioeconomic Deprivation among 488,107 People in Primary Care: A Cohort Study

DOI: 10.21203/rs.3.rs-144018/v1

Year: 2021

Risk of major bleeding by ethnicity and socioeconomic deprivation among 488,107 people in primary care: a cohort study

DOI: 10.1186/s12872-021-01993-9

Year: 2021

Prediction of first cardiovascular disease event in 2.9 million individuals using Danish administrative healthcare data: a nationwide, registry-based derivation and validation study

DOI: 10.1093/ehjopen/oeab015

Year: 2021

Cardiovascular Risk Prediction in Type 2 Diabetes Before and After Widespread Screening: A Derivation and Validation Study

DOI: 10.2139/ssrn.3742283

Year: 2020

What Role Does Technology Play in Behavioral Health Epidemiology?

Where Can One Obtain Enhanced Training?

What Roles Do They Play?

Why is Jargon Overused?

What Interventions Can Mitigate the Impact of RE?

What are the major risk factors for cardiovascular diseases?

What is Hemoglobin A1c?

What is Surgical Clipping?

How Can Epidemiologists Use Data from Particulate Matter Sensors?

Why is Lag Time Important?

Partnered Content Networks

Relevant Topics